NAS:IBB
iShares Biotechnology ETF | |
| $ 213.81 0.01 ( +0%) 04:00 PM EST | |
PE Ratio:
22.36
PB Ratio:
4.99
Volume:
1.61M
Dividend Yield %:
0.19
| |
| Last Holding update 2026-08-25 | 239 Stocks (0 new) |
| Value $9.08 Bil | Turnover 4 % |
Registrant: iShares Biotechnology ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
7 /10
Profitability Rank
5 /10
GF Value Rank
5 /10
Growth Rank
8 /10
Momentum Rank
5 /10
iShares Biotechnology ETF Geographic Breakdown
iShares Biotechnology ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
iShares Biotechnology ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 214.7 | ||
| Day's Range ($) | 211.49 - 214.94 | ||
| Day's Volume | 1,614,220 | ||
| 52-Week Range ($) | 138.79 - 217.12 | ||
| Beta | 0.719 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 0.92 | ||
| Volatility | 19.42 | ||
| 14-Day RSI | 64.07 | ||
| 14-Day ATR ($) | 4.090728 | ||
| 20-Day SMA ($) | 207.881 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 10,765.334 | ||
| Shares Outstanding (Mil) | 50.35 | ||
| PE Ratio | 22.36 | ||
| PE Ratio (10y Range) | 12.7 - 74.16 | ||
| PE Ratio (10y Median) | 21.8 | ||
| PB Ratio | 4.99 | ||
| PB Ratio (10y Range) | 1.69 - 7.5 | ||
| PB Ratio (10y Median) | 4.79 |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | 0.412 | ||
| Dividend Yield % | 0.19 | ||
| Dividend Yield % (10y Range) | 0.12 - 0.45 | ||
| Dividend Yield % (10y Median) | 0.26 | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
IBB iShares Biotechnology ETF Fundamental Charts
Historical TTM Price-to-Earnings for IBB iShares Biotechnology ETF
Historical TTM Price-to-Earnings without NRI for IBB iShares Biotechnology ETF
Historical Price-to-Book Ratio for IBB iShares Biotechnology ETF
Historical Dividend Yields for IBB iShares Biotechnology ETF
iShares Biotechnology ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with NAS:IBB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IBB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iShares Biotechnology ETF Top Holdings of 2026-06-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | 1,478,300 | 734,316.0 | +9.18% | 8.090 | +0.68% | 0.580 | +30.26% | +23.07% | 141,421.1 | Biotechnology | |
AMGN | Amgen Inc | 1,964,435 | 711,361.2 | +13.34% | 7.840 | +0.92% | 0.360 | +32.08% | +38.46% | 240,105.5 | Drug Manufacturers | |
GILD | Gilead Sciences Inc | 4,921,526 | 621,785.6 | +8.99% | 6.850 | +0.56% | 0.400 | +18.00% | +24.72% | 187,506.0 | Drug Manufacturers | |
REGN | Regeneron Pharmaceuticals Inc | 715,060 | 445,868.5 | -5.69% | 4.910 | -0.41% | 0.690 | +36.43% | +9.70% | 86,839.4 | Biotechnology | |
ARGX | argenx SE | 368,177 | 341,583.6 | +7.69% | 3.760 | +0.27% | 0.590 | +29.55% | +25.27% | 66,167.3 | Biotechnology | |
ALNY | Alnylam Pharmaceuticals Inc | 942,174 | 283,622.6 | -3.82% | 3.120 | -0.15% | 0.700 | -9.60% | -33.48% | 35,392.5 | Biotechnology | |
NTRA | Natera Inc | 967,683 | 262,677.5 | -1.32% | 2.890 | -0.03% | 0.670 | +54.67% | +43.03% | 47,231.7 | Medical Diagnostics & Research | |
RVMD | Revolution Medicines Inc | 1,349,118 | 252,662.8 | +5.08% | 2.780 | +0.13% | 0.630 | +35.18% | +164.75% | 45,197.1 | Biotechnology | |
BIIB | Biogen Inc | 1,037,164 | 224,089.6 | -4.94% | 2.470 | -0.12% | 0.700 | +14.57% | +27.57% | 33,172.3 | Drug Manufacturers | |
ILMN | Illumina Inc | 1,069,358 | 188,025.2 | -3.43% | 2.070 | -0.06% | 0.710 | +29.68% | +69.00% | 33,470.7 | Medical Diagnostics & Research |
iShares Biotechnology ETF's Historical Top Holdings Breakdowns
iShares Biotechnology ETF's Top Stock Picks
View Full List
| Ticker |
|---|
AMGN |
VRTX |
GILD |
| ACLX Unlock Delisted |
| TERN Unlock Delisted |
REGN |
| FOLD Unlock Delisted |
| APLS Unlock Delisted |
ASND |
ARGX |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
AMGN | Amgen Inc | 2026-06-30 | Add Add | +0.92% | 323.85 ($342.47) 362.12 | $444.12 | 29.68% | Add 13.34% | 1,964,435 | 231,287 | |
VRTX | Vertex Pharmaceuticals Inc | 2026-06-30 | Add Add | +0.68% | 423.24 ($443.24) 499.65 | $557.96 | 25.88% | Add 9.18% | 1,478,300 | 124,267 | |
GILD | Gilead Sciences Inc | 2026-06-30 | Add Add | +0.56% | 121.48 ($131.88) 142.09 | $151.22 | 14.66% | Add 8.99% | 4,921,526 | 405,819 | |
| ACLX Unlock Delisted | Arcellx Inc | 2026-06-30 | Sold Out Sold Out | -0.48% | 114.72 ($114.93) 115.1 | $115.07 | 0.12% | Sold Out | 0 | -335,814 | |
| TERN Unlock Delisted | Terns Pharmaceuticals Inc | 2026-06-30 | Sold Out Sold Out | -0.46% | 52.56 ($52.79) 52.95 | $52.95 | 0.30% | Sold Out | 0 | -713,848 | |
REGN | Regeneron Pharmaceuticals Inc | 2026-06-30 | Reduce Reduce | -0.41% | 600.66 ($682.14) 777.25 | $843.47 | 23.65% | Reduce -5.69% | 715,060 | -43,172 | |
| FOLD Unlock Delisted | Amicus Therapeutics Inc | 2026-06-30 | Sold Out Sold Out | -0.41% | 14.44 ($14.46) 14.49 | $14.49 | 0.21% | Sold Out | 0 | -2,307,725 | |
| APLS Unlock Delisted | Apellis Pharmaceuticals Inc | 2026-06-30 | Sold Out Sold Out | -0.39% | 40.23 ($40.86) 41.12 | $41.03 | 0.42% | Sold Out | 0 | -778,245 | |
ASND | Ascendis Pharma AS | 2026-06-30 | Add Add | +0.29% | 205.81 ($232.73) 266.72 | $271.12 | 16.50% | Add 28.88% | 438,135 | 98,187 | |
ARGX | argenx SE | 2026-06-30 | Add Add | +0.27% | 730.25 ($823.44) 927.77 | $1,053.46 | 27.93% | Add 7.69% | 368,177 | 26,294 |
iShares Biotechnology ETF Total Holding History ($B)
iShares Biotechnology ETF's Asset Allocation
iShares Biotechnology ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
iShares Biotechnology ETF's Hypothetical Growth since 2026-06-30
iShares Biotechnology ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
iShares Biotechnology ETF's Holdings Heat Map
Size field: